If lymph node involvement is confirmed inside a client going through neoadjuvant therapy who is a possible applicant for specific axillary dissection (TAD), a marker ought to be inserted from the lymph node just after biopsy.Significant is the exact documentation of the tumor location before, during and after NST (LoE 5D Back ++). Sentinel node exc